Placebo effects in randomized trials of pharmacological and neurostimulation interventions for mental disorders: An umbrella review.

Journal: Molecular psychiatry

Volume: 

Issue: 

Year of Publication: 

Affiliated Institutions:  Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK. n.huneke@soton.ac.uk. Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK. School of Psychology, University of Nottingham Malaysia, Semenyih, Malaysia. Centre for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK. Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin Berlin, Berlin, Germany. Faculty of Education and Psychology, University of Navarra, Pamplona, Spain. Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK. Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. Department of Translational Biomedicine and Neuroscience (DIBRAIN), University of Studies of Bari "Aldo Moro", Bari, Italy. Southern Health NHS Foundation Trust, Southampton, UK.

Abstract summary 

There is a growing literature exploring the placebo response within specific mental disorders, but no overarching quantitative synthesis of this research has analyzed evidence across mental disorders. We carried out an umbrella review of meta-analyses of randomized controlled trials (RCTs) of biological treatments (pharmacotherapy or neurostimulation) for mental disorders. We explored whether placebo effect size differs across distinct disorders, and the correlates of increased placebo effects. Based on a pre-registered protocol, we searched Medline, PsycInfo, EMBASE, and Web of Knowledge up to 23.10.2022 for systematic reviews and/or meta-analyses reporting placebo effect sizes in psychopharmacological or neurostimulation RCTs. Twenty meta-analyses, summarising 1,691 RCTs involving 261,730 patients, were included. Placebo effect size varied, and was large in alcohol use disorder (g = 0.90, 95% CI [0.70, 1.09]), depression (g = 1.10, 95% CI [1.06, 1.15]), restless legs syndrome (g = 1.41, 95% CI [1.25, 1.56]), and generalized anxiety disorder (d = 1.85, 95% CI [1.61, 2.09]). Placebo effect size was small-to-medium in obsessive-compulsive disorder (d = 0.32, 95% CI [0.22, 0.41]), primary insomnia (g = 0.35, 95% CI [0.28, 0.42]), and schizophrenia spectrum disorders (standardized mean change = 0.33, 95% CI [0.22, 0.44]). Correlates of larger placebo response in multiple mental disorders included later publication year (opposite finding for ADHD), younger age, more trial sites, larger sample size, increased baseline severity, and larger active treatment effect size. Most (18 of 20) meta-analyses were judged 'low' quality as per AMSTAR-2. Placebo effect sizes varied substantially across mental disorders. Future research should explore the sources of this variation. We identified important gaps in the literature, with no eligible systematic reviews/meta-analyses of placebo response in stress-related disorders, eating disorders, behavioural addictions, or bipolar mania.

Authors & Co-authors:  Huneke Nathan T M NTM Amin Jay J Baldwin David S DS Bellato Alessio A Brandt Valerie V Chamberlain Samuel R SR Correll Christoph U CU Eudave Luis L Garner Matthew M Gosling Corentin J CJ Hill Catherine M CM Hou Ruihua R Howes Oliver D OD Ioannidis Konstantinos K Köhler-Forsberg Ole O Marzulli Lucia L Reed Claire C Sinclair Julia M A JMA Singh Satneet S Solmi Marco M Cortese Samuele S

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Evers AWM, Colloca L, Blease C, Annoni M, Atlas LY, Benedetti F, et al. Implications of placebo and nocebo effects for clinical practice: Expert Consensus. Psychother Psychosom. 2018;87:204–10.
Authors :  21
Identifiers
Doi : 10.1038/s41380-024-02638-x
SSN : 1476-5578
Study Population
Male,Female
Mesh Terms
Other Terms
Study Design
Randomized Control Trial
Study Approach
Quantitative,Systemic Review
Country of Study
Publication Country
England